Introduction
Venous thromboembolism (VTE) is a common condition that affects 1-2% of the population, with an annual incidence of 1.31 in 1000 [1] . It comprises both deep vein thrombosis (DVT) and pulmonary embolism, and usually develops in the veins of the lower limbs in areas of reduced blood flow or endothelial injury. VTE can lead to death through pulmonary embolism, can induce the post-thrombotic syndrome, which is characterized by chronic leg pain, swelling, and ulceration [2] , or can result in chronic pulmonary hypertension, resulting in significant chronic respiratory compromise. VTE is the most common cardiovascular disease after myocardial infarction and ischemic stroke, and is a clinical challenge, as it can complicate the course of cancer, systemic disease, surgery, and major trauma [3] . Therefore, VTE has been shown to be a major health and economic burden worldwide [4] . Innate immunity is involved in DVT development. Using a flow restriction model of venous thrombosis, von Br€ uhl et al. demonstrated that neutrophils represent ⁓ 70% of the leukocyte population in venous thrombi, and that neutropenic mice were protected against thrombus formation [5] . At the site of thrombosis, neutrophils release their DNA in a net-like fashion to create neutrophil extracellular traps (NETs). NETs are composed of chromatin, histones, and neutrophil granule proteins [6, 7] . Circulating nucleosomes (chromatin plus histones) and neutrophil granule proteins are associated with a three-fold higher risk of DVT in humans [7] . NETs have several prothrombotic properties: (i) NETs have a polyanionic surface that activates factor XII, leading to initiation of the intrinsic pathway of the coagulation cascade [5] ; (ii) tissue factor binds to NETs, leading to activation of the extrinsic pathway of the coagulation cascade [8] ; and (iii) NET-associated extracellular histones induce thrombin generation by platelets [9] and release von Willebrand factor from Weibel-Palade bodies in endothelial cells, leading to platelet and leukocyte adhesion [10] . Clinically, the role of NETs in venous thrombosis has also been demonstrated. Patients suffering from venous thrombosis had increased levels of free circulating DNA and increased levels of activated neutrophils [7, 11, 12] .
Although the mechanisms of NET release have been described, the trigger for their formation in the context of venous thrombosis remains understudied [13, 14] . In general, bacteria, viruses, lipopolysaccharide (LPS), platelets and cytokines can induce NET formation [15] . In experimental models, cytokines are produced during venous thrombosis [5, 16] . It was found that neutrophils had increased sensitivity to interferon (IFN)-c and that, in vitro, IFN-c induced the formation of NETs by neutrophils [17] . IFN-c is a proinflammatory cytokine that has been implicated in several cardiovascular diseases, including hypertension, atherosclerosis, angiogenesis, and venous thrombosis [18] [19] [20] [21] [22] . Therefore, we hypothesize that, in the context of venous thrombosis, IFN-c triggers NET formation with subsequent venous thrombosis development.
Materials and methods

Animals
All experiments were approved by the institutional animal care and use committee. Healthy male wild-type (WT),
) and IFNc À/À mice on a C57BL/6J background were purchased from Jackson Laboratory (Bar Harbor, Maine, USA), and used as experimental animals when they were between 8 weeks and 12 weeks of age, and had a body weight ranging from 20.1 g to 30.5 g. There were no statistically significant differences in age and weight between the different groups at the time when experiments were performed.
Venous thrombosis model
The flow restriction model was used as previously described [16] . Briefly, the inferior vena cava (IVC) was exposed and separated from the abdominal aorta just caudal to the left renal vein. A blunted 30G needle was placed on the exposed vessel, and ligation of the vessel around the needle was performed with a permanent ligature (6-0 Perma-Hand Silk; Ethicon, Somerville, NJ, USA). Subsequently, the needle was carefully removed to create partial ligation. There was no ligation of side branches, and all mice with bleeding and/or injury of the IVC were excluded and killed. To ensure proper flow restriction, the cross-sectional area of the IVC and flow were measured before the procedure, and 48 h after the procedure, with the Vevo 770 (Visualsonics, Toronto, Ontario, Canada), as previously described [16, 23, 24] . After the procedure, the cross-sectional area of the IVC was reduced by 90% and the flow was reduced by 75% (Fig. S1 ). There was no difference between the groups of mice regarding the number of excluded animals or degree of restriction. The numbers of mice that developed a thrombus following flow restriction in the different groups (WT, Tbet À/À , and IFN-c
, treated or not) are shown in Table S1 .
In additional experiments, the stasis model was also used to induce venous thrombosis. The experimental procedure is similar to that for flow restriction described above, except that the IVC was fully occluded with a 6-0 silk suture and side branches were ligated. 
Flow cytometry
Flow cytometry analysis was performed on blood of WT mice injected with either the Asialo GM1 or control isotype antibody. A minimum of 50 lL of whole blood was collected by cardiac puncture and placed in EDTA tubes.
Red blood cells (RBCs) were lysed with RBC lysis buffer (BioLegend). Samples were incubated with a phycoerythrin (PE)-conjugated anti-mouse NK1.1 antibody (BD Bioscience, Mississauga, Ontario, Canada) and an allophycocyanin (APC)-conjugated anti-mouse T-cell receptor-b (TCRb) antibody (Thermo Fisher Scientific, Mississauga, Ontario, Canada).
Flow cytometry was performed on the BD LSR Fortessa (BD Biosciences, Mississauga, Ontario, Canada). All antibodies minus one were mixed to determine background fluorescence and positive staining. Data analysis was performed with FLOWJO (Tree Star, Ashland, OR, USA).
Gating was first performed on forward versus side scatter to remove debris and doublets before selection of live cells based on exclusion with a viability dye (7-aminoactinomycin D). NK cells were selected on the basis of their expression of the NK1.1 marker after exclusion of TCRb-positive cells.
For the NK depletion experiments with the anti-NK1.1 antibody, a few drops of blood were collected from the saphenous veins of injected mice after 3 days. Blood was incubated with CD45 (AF700; 30-F11), CD4 (PerCPCy5.5; RM4-5), CD8 (APC-eF780; 53-6.7), CD11b (APC; M1/70), B220 (PE-Cy7; RA3-6B2), NK1.1 (PE; PK136), and Ly6G (AF488; 1A8), and analyzed as described above.
Histology and immunofluorescence staining of thrombi
Serial frozen sections (7 lm) of thrombus and vein were prepared as previously described [16] . For histology, slides were stained with hematoxylin and eosin. Thrombus area was quantified with IMAGEJ (NIH, Bethesda, MD, USA). For immunofluorescence staining, samples were prepared as previously described [16] , and stained with the following antibodies: rat anti-mouse Ly6G (Thermo Fisher Scientific), rat anti-mouse MOMA-2 (Abcam, Cambridge, UK), and rabbit anti-mouse Asialo GM1 (Cedarlane, Burlington, Ontario, Canada). For NET staining, slides were incubated overnight at 4°C with rabbit anti-mouse citrullinated histone H3. Appropriate secondary AlexaFluor-conjugated antibodies were used for detection (anti-rat 555 nm and anti-rabbit 488 nm; Thermo Fisher Scientifc). Images were acquired with a Leica (Wetzlar, Germany) DM 2000 fluorescence microscope (9 5, 9 20, and For coculture experiments, 10 6 WT or IFN-c À/À NK cells were cultured with 10 5 WT neutrophils. NK cells and neutrophils were separated by a 0.4-lm transwell insert to avoid them coming into direct contact. PBS was used as a negative control, and rIFN-c was used as a positive control.
Statistical analysis
Statistical analysis was performed with the commercially available software PRISM (GraphPad Software, San Diego, CA, USA). Normality was assessed with a Shapiro-Wilk test. Normally distributed data were reported as mean AE standard error of the mean, and compared by use of an unpaired t-test. Non-parametric data were reported as median and range, and compared by use of a Mann-Whitney U-test. For multiple comparisons, one-way ANOVA followed by Tukey's post hoc test was performed. Categorical data were compared by use of a chi-square test or Fisher's exact test, depending on the numbers expected. For all comparisons, a Pvalue of < 0.05 was considered to be significant.
Results
Tbet promotes thrombus formation
Tbet is a transcription factor that is required for IFN-c production [25, 26] . To evaluate the role of Tbet in thrombus formation, venous thrombosis was induced in Tbet À/ À mice by use of the flow restriction model (Fig. S1A) .
Interestingly, absence of Tbet reduced thrombus size, thrombus weight and thrombus section area as compared with WT mice (Fig. 1A-C) . Next, we assessed thrombus formation in IFN-c À/À mice (Fig. S1B) . Similarly to what was found in Tbet À/À mice, absence of IFN-c resulted in the formation of significantly smaller thrombi than in WT controls (Fig. 1D,E ). This suggests that Tbet + / IFN-c-producing cells promote thrombus formation.
To validate the prothrombotic role of IFN-c, murine rIFN-c was administered to Tbet À/À and IFN-c À/À mice.
Intraperitoneal injection of rIFN-c resulted in an increase in the level of circulating IFN-c (Fig. S3A,B) . Interestingly, rIFN-c administration increased the size of thrombi in Tbet À/À and IFN-c À/À mice to levels comparable to those in WT mice (Fig. 1F,G) . In parallel, WT mice were injected with an IFN-c-blocking antibody. Blocking IFNc resulted in a significant decrease in the level of circulating IFN-c (Fig. S3C) , which was associated with a decrease in thrombus formation (Fig. 1H ).
Tbet and IFN-c promote NET formation by neutrophils
To define the role of Tbet and IFN-c in thrombus formation, we compared the thrombus cellular content from Tbet
, IFN-c À/À and WT mice. There was no difference in neutrophil or monocyte content between WT, Tbet À/À or IFN-c À/À mice (Fig. S4A,B) . These data suggest that Tbet and IFN-c are not involved in neutrophil or monocyte recruitment. Neutrophils constitute the main cellular component of thrombi, and mainly participate in thrombosis by releasing NETs [5] . We investigated NET formation in thrombi from Tbet À/À , IFN-c À/À and WT mice. Although the numbers of neutrophils per thrombus area were not significantly different, significantly fewer neutrophils formed NETs in Tbet À/À and IFN-c À/À mice than in WT mice ( Fig. 2A) . These data suggest that IFN-c promotes NET formation during venous thrombosis.
In vitro, treatment of WT neutrophils with rIFN-c induced NET formation similarly to LPS and recombinant TNF-a (Fig. 2B) . Additionally, injection of rIFN-c into IFN-c À/À mice significantly increased the number of NETs (Fig. 2C) . Finally, in WT mice injected with an IFN-c-blocking antibody, the number of NETs was significantly decreased (Fig. 2D ). These data show that IFN-c is directly involved in NET formation during venous thrombosis.
NK cells promote thrombus formation
NK cells are the main producers of IFN-c. Therefore, we investigated the role of NK cells in thrombus formation. Injection of an Asialo GM1 antibody resulted in significant and prolonged depletion of NK cells in WT mice (Fig. S5A ). In our venous thrombosis model (Fig. S5B) , depletion of NK cells reduced thrombus size and thrombus section area (Fig. 3A,B) , confirming that NK cells participate in thrombus formation.
IFN-c staining was also reduced in thrombi of NK cell-depleted mice (Fig. 3Ci) . IFN-c serum levels were also reduced after venous thrombosis in mice treated with the GM1 antibody (Fig. 3Cii) . These data suggest that the presence of NK cells is required for sustained IFN-c production during venous thrombosis. NK cell depletion did not change the neutrophil or monocyte content (Fig. S6) . However, the number of NETs was significantly decreased in NK cell-depleted mice (Fig. 3D) . These experiments strongly suggest that NK cells promote thrombus development through IFN-c production.
NK cells promote VTE through IFN-c
To definitively demonstrate that NK cells are the cells producing the IFN-c that induces venous thrombosis, WT mice were injected with an NK1.1-blocking antibody and received adoptive transfer of either WT or IFN-c -/-NK cells (Fig. 4) . We first showed that injection of WT NK cells into WT mice significantly increased thrombus size as compared with WT NK cell-depleted mice NK cells. We then demonstrated that WT mice injected with IFN-c À/À NK cells developed smaller thrombi than mice receiving WT NK cells (Fig. 4D ). In addition, NET formation was significantly inhibited in NK cell-depleted mice injected with IFN-c À/À NK cells as compared with mice receiving WT NK cells (Fig. 4E) . soluble factor, possibly IFN-c, produced by NK cells induces NET formation (Fig. 5 ).
Discussion
Our study reveals a new mechanism for NET formation during venous thrombosis. We have demonstrated that NET formation is dependent on the secretion of IFN-c by NK cells, which contributes to venous thrombosis.
Studies have shown that several cytokines are produced during venous thrombosis, and contribute to the recruitment of monocytes and neutrophils [5, 16] . Recent evidence has implicated IFN-c as an important factor during thrombolysis. Nosaka et al. showed that IFN-c delays thrombus resolution by inhibiting matrix metalloproteinase-9 production by monocytes, and Schonfelder et al. demonstrated that absence of Tbet accelerates thrombus resolution by inhibiting interleukin-12 formation by monocytes [21, 27] . In addition, Luther et al. recently confirmed that IFN-c delays thrombus neovascularization and resolution [22] . IFN-c is an inflammatory cytokine produced by immune cells, and promotes inflammatory processes such as macrophage activation, and expression of chemokines and adhesion molecules involved in the recruitment of immune cells. Although NK T cells, T-helper cells, macrophages and dendritic cells have also been shown to produce IFN-c, NK cells are the main producers of IFN-c, confirming that the effects observed in our study may be attributable to NK cells [18, 28] .
NK cells are innate lymphocytes, and represent⁓2 % of the lymphocytes in the spleen, and between 2% and 18% of the lymphocytes in peripheral blood [29] . NK cells constitute an early line of defense against pathogens or tumor cells, and are powerful producers of cytokines such as TNF-a, granulocyte-macrophage colony-stimulating factor, and IFN-c. NK cells also induce cell death through cytotoxic activities, including degranulation and secretion of death molecules, such as perforin and granzyme B, and through the TNF death receptor family (Fas ligand and TRAIL) [30] . NK cells have also been shown to be important in several cardiovascular disorders, including hypertension, atherosclerosis, and angiogenesis [18, 20, 31] . In NK cells, the expression of IFN-c is partly regulated by the transcription factor Tbet. We have demonstrated that both Tbet and IFN-c deficiency significantly reduce thrombus formation. When Tbet-deficient and IFN-cdeficient mice were treated with rIFN-c, thrombus size reverted to that of WT mice, demonstrating a direct effect of IFN-c in the formation of venous thrombosis. More importantly, similar results were obtained in mice depleted of NK cells, showing that NK cells promote venous thrombosis through the secretion of IFN-c. However, the effect of Tbet deletion on thrombus size is greater than the effect of IFN-c deficiency. Thus, we cannot rule out the possibility that other cells expressing Tbet, i.e. T cells or monocytes, are involved in thrombus formation [16, 22] .
As mentioned above, it has been suggested that IFN-cproducing cells may promote the recruitment of monocytes and neutrophils during venous thrombosis [22] . We have shown here that monocyte and neutrophil recruitment was equivalent between WT, Tbet À/À and IFN-c
mice. Thus, we sought to investigate the role of IFN-c in NET formation, which has been described as a major prothrombotic mechanism during flow restriction in mice [5] . We observed that NET formation was reduced within thrombi of Tbet À/À and IFN-c À/À mice as compared with those of WT mice. More importantly, we found that injection of IFN-c into IFN-c À/À mice increased NET formation during venous thrombosis. Previous studies have shown that IFN-c induces the formation of NETs from cultured neutrophils or monocytes in combination with other agents [17, 32] . In contrast, our study has shown that IFN-c alone induces the formation of NETs both in vivo and in vitro. Although minor differences may have been caused by different genetic backgrounds, we have demonstrated in vivo that NET formation is reduced in mice deficient for Tbet or IFN-c. This effect can be abrogated by injection of rIFNc into deficient mice. NK cell depletion also reduces the formation of NETs within thrombi, supporting the idea that NK cells promote neutrophil activation. More importantly, we found that adoptive transfer of IFN-c À/À NK cells had no effect on thrombus size or NET formation in mice depleted of endogenous NK cells, whereas injection of WT NK cells was associated with an increased thrombus burden and NET formation. These data strongly suggest that NK cells promote venous thrombosis through IFN-c-dependent NET formation. ) mobilization and reactive oxygen species (ROS) production, which leads to chromatin decondensation driven by peptidylarginine deiminase 4 and release of the nuclear content into the extracellular space. Studies have shown that IFN-c induces ROS production and changes in the cytosolic Ca 2+ concentration [33, 34] . Although we do not have direct evidence of how IFN-c induces NET formation, one can speculate that, during venous thrombosis, the IFN-c secreted by NK cells enhances Ca 2+ flux and ROS production in neutrophils, leading to the formation of NETs.
Overall, this study provides additional insights into the links between thrombosis and inflammation, and reinforces the role of innate immune cells in venous thrombosis. More importantly, this study provides new data regarding the formation of NETs in the context of venous thrombosis. Our results demonstrate that NK cells are crucial for NET formation through IFN-c, and promote venous thrombosis. equivalent between WT, Tbet À/À and IFNc À/À mice (n = 6). Scale bar: 50 lm. Fig. S5 . NK cell depletion. Fig. S6 . Treatment with the anti-Asialo GM1 antibody does not affect monocyte and neutrophil populations within thrombi. Table S1 . Formation of thrombi in mice of different genotypes and subjected to different treatments after 48 h of flow restriction.
Addendum
